ATP7B and Wilson disease: All participants underwent clinical evaluation, assessment of copper metabolism, including CuEXC and REC, and genetic testing for ATP7B. Receiver operating characteristic curve analysis was used to assess the diagnostic performance of REC and to determine the optimal cut-off for diagnosing WD.